About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics 01-11-2021 at 4:01 PM EST Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference 12-30-2020 at 4:30 PM EST Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of clonoSEQ® Assay on Patients with Blood Cancers at the 62nd ASH Annual Meeting 12-06-2020 at 10:00 AM EST VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations 39th Annual J.P. Morgan Healthcare Conference Jan 11, 2021 at 4:30 PM EST Listen to webcast View Presentation 2.8 MB Adaptive Biotechnologies Third Quarter Financial Results Nov 10, 2020 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Third Quarter Financial Results Presentation 1.6 MB Cowen’s Liquid Biopsy Summit Sep 24, 2020 at 8:30 AM EDT View Presentation 1 MB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Jan 27, 2021 1:34 AM ESTData Provided by Refinitiv. Minimum 15 minutes delayed.
